Literature DB >> 3844973

Modulation of formation of tumor metastases by peritoneal macrophages elicited by various agents.

E Gorelik, R H Wiltrout, D Copeland, R B Herberman.   

Abstract

We have studied the formation of experimental B16 melanoma metastases in the lungs of mice inoculated IV with tumoricidal or nontumoricidal peritoneal macrophages elicited by various agents. IV inoculation of peritoneal M phi elicited by Brewer's thioglycollate medium (TG-M phi) 1 day before the injection of B16 melanoma cells dramatically increased the number of metastatic foci in the lungs. NIH thioglycollate broth and proteose peptone each elicited a relatively low number of M phi, which were morphologically distinguishable from TG-M phi and did not influence the yield of B16 melanoma colonies in the lungs. Resident or C. pravum-elicited M phi also did not augment metastasis formation. TG-M phi became highly tumoricidal after IP stimulation with poly I:C. However, tumoricidal TG-M phi inoculated IV 1 day before IV inoculation of B16 melanoma cells did not have an antimetastatic effect. On the contrary, both tumoricidal and nontumoricidal TG-M phi augmented metastasis formation. Poly I:C treatment had a substantial antimetastatic effect in the normal mice, but not in mice with adoptively transferred TG-M phi. Histological analysis revealed that IV-inoculated TG-M phi (tumoricidal or nontumoricidal, either viable or disrupted) induced severe intravascular reaction in the lungs, but not in the liver or kidney. This reaction manifested in the aggregation of the various blood cells, preferentially neutrophils. These reactions were not observed after IV inoculation of PM phi or NIH TG-M phi. Intravascular inflammatory reactions induced by TG-M phi may be responsible for the augmentation of metastasis formation, partly by suppression of NK reactivity and mostly by the acceleration of the processes of tumor cell extravasation. These data may provide some insight into the failure to achieve systemic adoptive immunotherapy using activated peritoneal TG-M phi.

Entities:  

Mesh:

Year:  1985        PMID: 3844973     DOI: 10.1007/bf00199309

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  24 in total

1.  Comparison of antiviral and antitumor activity of activated macrophages.

Authors:  P S Morahan; L A Glasgow; J L Crane; E R Kern
Journal:  Cell Immunol       Date:  1977-02       Impact factor: 4.868

2.  Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage.

Authors:  T Sacks; C F Moldow; P R Craddock; T K Bowers; H S Jacob
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

3.  Neutrophil aggregating properties of PAF-acether and leukotriene B4.

Authors:  A W Ford-Hutchinson
Journal:  Int J Immunopharmacol       Date:  1983

4.  Measurement of macrophage-mediated cytotoxicity against adherent and non-adherent target cells by release of 11 indium-oxine.

Authors:  R H Wiltrout; D Taramelli; H T Holden
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

5.  Effect of intravascular complement activation on granulocyte adhesiveness and distribution.

Authors:  J T O'Flaherty; P R Craddock; H S Jacob
Journal:  Blood       Date:  1978-04       Impact factor: 22.113

6.  Phorbol myristate acetate: in vivo effects upon neutrophils, platelets, and lung.

Authors:  J T O'Flaherty; S Cousart; A S Lineberger; E Bond; D A Bass; L R DeChatelet; E S Leake; C E McCall
Journal:  Am J Pathol       Date:  1980-10       Impact factor: 4.307

7.  Augmentation of metastasis formation by thioglycollate-elicited macrophages.

Authors:  E Gorelik; R H Wiltrout; M J Brunda; H T Holden; R B Herberman
Journal:  Int J Cancer       Date:  1982-05-15       Impact factor: 7.396

8.  Contrasting effects of activated and nonactivated macrophages and macrophages from tumor-bearing mice on tumor growth in vivo.

Authors:  A Gabizon; S J Leibovich; R Goldman
Journal:  J Natl Cancer Inst       Date:  1980-11       Impact factor: 13.506

9.  Studies of the macrophage complement receptor. Alteration of receptor function upon macrophage activation.

Authors:  C Bianco; F M Griffin; S C Silverstein
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

10.  Role of activated macrophages in antibody-dependent lysis of tumor cells.

Authors:  C Nathan; L Brukner; G Kaplan; J Unkeless; Z Cohn
Journal:  J Exp Med       Date:  1980-07-01       Impact factor: 14.307

View more
  8 in total

1.  Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential.

Authors:  D R Welch; A Fabra; M Nakajima
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

2.  Apoptosis resistance and PKC signaling: distinguishing features of high and low metastatic cells.

Authors:  Sung-Hyeok Hong; Ling Ren; Arnulfo Mendoza; Ananth Eleswarapu; Chand Khanna
Journal:  Neoplasia       Date:  2012-03       Impact factor: 5.715

3.  Influence of adoptively transferred thioglycollate-elicited peritoneal macrophages on metastasis formation in mice with depressed or stimulated NK activity.

Authors:  E Gorelik; R H Wiltrout; M J Brunda; W E Bere; R B Herberman
Journal:  Clin Exp Metastasis       Date:  1985 Apr-Jun       Impact factor: 5.150

Review 4.  Revisiting the seed and soil in cancer metastasis.

Authors:  Martin Mendoza; Chand Khanna
Journal:  Int J Biochem Cell Biol       Date:  2009-02-03       Impact factor: 5.085

5.  Tumor-elicited polymorphonuclear cells, in contrast to "normal" circulating polymorphonuclear cells, stimulate invasive and metastatic potentials of rat mammary adenocarcinoma cells.

Authors:  D R Welch; D J Schissel; R P Howrey; P A Aeed
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

6.  Recruitment of exogenous macrophages into metastases at different stages of tumor growth.

Authors:  P J Bugelski; R Kirsh; C Buscarino; S P Corwin; G Poste
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

7.  Interactions between human macrophages and tumor cells in three-dimensional cultures.

Authors:  R Audran; L Dazord; L Toujas
Journal:  Cancer Immunol Immunother       Date:  1994-11       Impact factor: 6.968

8.  Interactions between human monocytes and tumour cells. Monocytes can either enhance or inhibit the growth and survival of K562 cells.

Authors:  B Davies; S W Edwards
Journal:  Br J Cancer       Date:  1992-09       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.